Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury

Clinical trial NCT01756508 · COMPLETED

Trial details

NCT number: NCT01756508
Sponsor: Russian Academy of Medical Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

End-Stage Renal Disease Kidney Failure Graft Reperfusion Injury

Start date: 2012-09-01
Primary completion: 2017-04-15
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.